Market Research Logo

Global CRISPR And CRISPR-Associated (Cas) Genes Market Professional Survey Report 2017

Global CRISPR And CRISPR-Associated (Cas) Genes Market Professional Survey Report 2017

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the CRISPR And CRISPR-Associated (Cas) Genes market by Application and end industries.

CRISPR And CRISPR-Associated (Cas) Genes market is expected to grow on the back of several drivers such as increased R&D expenditure on biotechnology, backed by venture capitals, increasing age related genetic disorders, increasing private and government expenditure on genetic research, high prevalence rate of genetic birth disorders and high demand of synthetic genes. Several factors such as limited awareness and little presence in emerging markets are restraints in the path of growth of the market.

The Global CRISPR And CRISPR-Associated (Cas) Genes market is segmented on the basis of application and end users: On the basis of application the market is segmented into Genome Editing, Genetic engineering, gRNA Database/Gene Library, CRISPR And CRISPR-Associated (Cas) Genes Plasmid and vectors so on. CRISPR And CRISPR-Associated (Cas) Genes Plasmid is the highest growing segment due to high demand among scientists and researchers. By end user, the market is segmented into Biotechnology companies, Pharmaceutical companies, Academic and research Institutes, Research and development institutes, Competitive Intelligence, Merger and Acquisitions and Innovation. In end user, the academic and research is highest growing segment due to high level of R&D into genome process, development of new drugs and development of genetically modified organisms and drugs.

The geography analysis consists of North America (US, Canada), Europe (United Kingdom, France, Germany, Spain, Italy), Asia Pacific (India, China, Japan, Southeast Asia) and Rest of the world. North America is the largest geographical market (2016) in CRISPR And CRISPR-Associated (Cas) Genes because high level of academies and research based in region. Asia-Pacific region is expected to grow at the fastest rate in forecasted period due to increase in number of contract research organization and emergence of drug discovery.

The major players in global market include
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon


1 Industry Overview
1.1 CRISPR And CRISPR-Associated (Cas) Genes Market Overview
1.1.1 CRISPR And CRISPR-Associated (Cas) Genes Product Scope
1.1.2 Market Status and Outlook
1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size and Analysis by Regions (2014-2017)
1.2.1 North America CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook
1.2.2 EU CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook
1.2.3 Japan CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook
1.2.4 China CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook
1.2.5 India CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook
1.2.6 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook
1.3 Classification of CRISPR And CRISPR-Associated (Cas) Genes by Application
1.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market (Million USD) by Application (2014-2022)
1.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share (%) by Application in 2016
1.4 CRISPR And CRISPR-Associated (Cas) Genes Market by End Users
2 Global CRISPR And CRISPR-Associated (Cas) Genes Competition Analysis by Players
3 Company (Top Players) Profiles and Key Data
3.1. Thermo Fisher Scientific
3.1.1. Company Basic Information and Main Business Overview
3.1.2. Technology/Product Introduction
3.1.3. Expenses, R&D Expenses and R&D Share
3.2. Editas Medicine
3.2.1. Company Basic Information and Main Business Overview
3.2.2. Technology/Product Introduction
3.2.3. Expenses, R&D Expenses and R&D Share
3.3. Caribou Biosciences
3.3.1. Company Basic Information and Main Business Overview
3.3.2. Technology/Product Introduction
3.3.3. Expenses, R&D Expenses and R&D Share
3.4. CRISPR therapeutics
3.4.1. Company Basic Information and Main Business Overview
3.4.2. Technology/Product Introduction
3.4.3. Expenses, R&D Expenses and R&D Share
3.5. Intellia therapeutics, Inc.
3.5.1. Company Basic Information and Main Business Overview
3.5.2. Technology/Product Introduction
3.5.3. Expenses, R&D Expenses and R&D Share
3.6. Cellectis
3.6.1. Company Basic Information and Main Business Overview
3.6.2. Technology/Product Introduction
3.6.3. Expenses, R&D Expenses and R&D Share
3.7. Horizon Discovery Plc
3.7.1. Company Basic Information and Main Business Overview
3.7.2. Technology/Product Introduction
3.7.3. Expenses, R&D Expenses and R&D Share
3.8. Sigma Aldrich
3.8.1. Company Basic Information and Main Business Overview
3.8.2. Technology/Product Introduction
3.8.3. Expenses, R&D Expenses and R&D Share
3.9. Precision Biosciences
3.9.1. Company Basic Information and Main Business Overview
3.9.2. Technology/Product Introduction
3.9.3. Expenses, R&D Expenses and R&D Share
3.10. Genscript
3.10.1. Company Basic Information and Main Business Overview
3.10.2. Technology/Product Introduction
3.10.3. Expenses, R&D Expenses and R&D Share
3.11. Sangamo Biosciences Inc.
3.11.1. Company Basic Information and Main Business Overview
3.11.2. Technology/Product Introduction
3.11.3. Expenses, R&D Expenses and R&D Share
3.12. Lonza Group Limited
3.12.1. Company Basic Information and Main Business Overview
3.12.2. Technology/Product Introduction
3.12.3. Expenses, R&D Expenses and R&D Share
3.13. Integrated DNA Technologies
3.13.1. Company Basic Information and Main Business Overview
3.13.2. Technology/Product Introduction
3.13.3. Expenses, R&D Expenses and R&D Share
3.14. New England Biolabs
3.14.1. Company Basic Information and Main Business Overview
3.14.2. Technology/Product Introduction
3.14.3. Expenses, R&D Expenses and R&D Share
3.15. Origene Technologies
3.15.1. Company Basic Information and Main Business Overview
3.15.2. Technology/Product Introduction
3.15.3. Expenses, R&D Expenses and R&D Share
4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by End User and Application (2014-2017)
4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by End User (2014-2017)
4.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Application (2014-2017)
4.3 Value Chain Analysis
5 North America CRISPR And CRISPR-Associated (Cas) Genes Development Status and Outlook
6 EU CRISPR And CRISPR-Associated (Cas) Genes Development Status and Outlook
7 Japan CRISPR And CRISPR-Associated (Cas) Genes Development Status and Outlook
8 China CRISPR And CRISPR-Associated (Cas) Genes Development Status and Outlook
9 India CRISPR And CRISPR-Associated (Cas) Genes Development Status and Outlook
10 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Development Status and Outlook
11 Market Forecast by Regions, Product and Application (2017-2022)
11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) (2017-2022)
11.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
11.3 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by End User (2017-2022)
12 CRISPR And CRISPR-Associated (Cas) Genes Market Dynamics
12.1 Sector Policy Analysis
12.2 Research and Development
12.2.1 Scientific Papers Analysis
12.2.2 Patent Analysis
12.3 CRISPR vs. Conventional Gene Editing Tools
12.4 CRISPR: Novel Initiatives
12.4.1 CRISPR Cas9 Technology
12.4.2 CRISPR as A Gene Editing Tool to Treat Genetic Disorders
12.4.3 CRISPR as A Gene Editing Tool In Drug Development
13 Market Effect Factors Analysis
13.1 Drivers
13.1.1 Rise in Drug Discovery Market
13.1.2 Demand for Synthetic Genes
13.1.3 High Prevalence of Genetic Birth Disorders
13.1.4 Age Related Genetic Disorders
13.1.5 Rise in the Healthcare Research and Development Budgets
13.1.6 Venture Capital
13.1.7 Global Increase in Lifestyle Oriented Diseases & Fatalities
13.1.8 GMOS Increase Crop Yields and Promote Efficient Land Use
13.2 Restraints
13.2.1 Ethical Issues Related to Misuse of CRISPR Gene Editing Tool
13.2.2 Limited Awareness
13.2.3 Limited Presence in Emerging Markets
13.3 Opportunities
13.3.1 CRISPR Gene Editing Can Open the Market for Gene Surgery
13.3.2 Emerging Contract Research Organization Market in Asia
13.4 Challenges
13.4.1 Patent Infringement
13.4.2 Presence of Alternative Gene Editing Tools
14 Research Finding /Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Disclaimer
15.4 Author List
List of Tables and Figures
Figure Brief History of CRISPR
Figure CRISPR Prokaryotic Antiviral Defense Mechanism
Table Global CRISPR Key Vendors
Table Global Market CRISPR And CRISPR-Associated (Cas) Genes (Million USD) Comparison by Regions 2014-2017
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Share by Regions 2016
Figure United States CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate (2014-2022)
Figure Canada CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate (2014-2022)
Figure United Kingdom CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure France CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Germany CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Spain CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Italy CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Japan CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure China CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure India CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Table Global CRISPR And CRISPR-Associated (Cas) Genes Market (Million USD) Comparison by Application (2014-2022)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Share (%) by Application in 2016
Table Global CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) Comparison by End Users (2014-2017)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Share by Application in 2016
Table Global CRISPR And CRISPR-Associated (Cas) Genes Expenses (K USD) by Players (2014-2017)
Table Global CRISPR And CRISPR-Associated (Cas) Genes Expenses Market Share (%) by Players (2014-2017)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Expenses Share by Players in 2015
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Expenses Share by Players in 2016
Table Thermo Fisher Company Basic Information and Main Business Overview
Table Technology/Product Introduction
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Thermo Fisher Scientific 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Thermo Fisher Scientific 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Thermo Fisher Scientific 2014-2017
Table Editas Medicine Company Basic Information and Main Business Overview
Table Pipeline of Editas Medicine
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Editas Medicine 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Editas Medicine 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Editas Medicine 2014-2017
Table Caribou Biosciences Company Basic Information and Main Business Overview
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Caribou Biosciences 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Caribou Biosciences 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Caribou Biosciences 2014-2017
Table CRISPR therapeutics Company Basic Information and Main Business Overview
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of CRISPR therapeutics 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of CRISPR therapeutics 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of CRISPR therapeutics 2014-2017
Table Intellia therapeutics, Inc. Company Basic Information and Main Business Overview
Table Three General Types of Edits
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Intellia therapeutics, Inc. 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Intellia therapeutics, Inc. 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Intellia therapeutics, Inc. 2014-2017
Table Cellectis Company Basic Information and Main Business Overview
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Cellectis 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Cellectis 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Cellectis 2014-2017
Table Horizon Discovery Plc Company Basic Information and Main Business Overview
Table Technology/Product Introduction
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Horizon Discovery Plc 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Horizon Discovery Plc 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Horizon Discovery Plc 2014-2017
Table Sigma Aldrich Company Basic Information and Main Business Overview
Table Product Introduction
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Sigma Aldrich 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Sigma Aldrich 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Sigma Aldrich 2014-2017
Table Precision Biosciences Company Basic Information and Main Business Overview
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Precision Biosciences 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Precision Biosciences 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Precision Biosciences 2014-2017
Table Genscript Company Basic Information and Main Business Overview
Table Technology/Product Introduction
Table GenCrispr/Cas9 Genome Editing Products
Table gRNA Constructs for CRISPR/Cas9 Genome Editing
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Genscript 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Genscript 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Genscript 2014-2017
Table Sangamo Biosciences Inc. Company Basic Information and Main Business Overview
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Sangamo Biosciences Inc. 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Sangamo Biosciences Inc. 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Sangamo Biosciences Inc. 2014-2017
Table Lonza Group Limited Company Basic Information and Main Business Overview
Table Technology/Product Introduction
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Lonza Group Limited 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Lonza Group Limited 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Lonza Group Limited 2014-2017
Table Integrated DNA Technologies Company Basic Information and Main Business Overview
Table Technology/Product Introduction
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Integrated DNA Technologies 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Integrated DNA Technologies 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Integrated DNA Technologies 2014-2017
Table New England Biolabs Company Basic Information and Main Business Overview
Table Product Introduction
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of New England Biolabs 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of New England Biolabs 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of New England Biolabs 2014-2017
Table Origene Technologies Company Basic Information and Main Business Overview
Table Product Introduction
Table CRISPR Expenses (K USD), R&D Expenses (K USD) and R&D Share of Origene Technologies 2014-2017
Figure CRISPR Expenses (K USD) and Growth Rate of Origene Technologies 2014-2017
Figure CRISPR Expenses (K USD) and Total Expenses Share of Origene Technologies 2014-2017
Table Global CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) by End User (2014-2017)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share (%) by End User (2014-2017)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Share by End User in 2016
Table Global CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) by Application (2014-2017)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share (%) by Application (2014-2017)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Share by Application in 2016
Figure Value Chain Analysis of CRISPR And CRISPR-Associated (Cas) Genes Market
Figure United States CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate (2014-2022)
Figure Canada CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate (2014-2022)
Figure United Kingdom CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure France CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Germany CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Spain CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Italy CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Japan CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure China CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure India CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate by Regions (2014-2022)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) and Growth Rate (Value) (2017-2022)
Table Global CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) by Application (2017-2022)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Application in 2022
Table Global CRISPR And CRISPR-Associated (Cas) Genes Market Size (Million USD) by End User (2017-2022)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by End User (2017-2022)
Figure Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by End User in 2022
Table Sector Policy Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report